Viewing Study NCT02016105


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-07-03 @ 10:16 PM
Study NCT ID: NCT02016105
Status: COMPLETED
Last Update Posted: 2017-05-30
First Post: 2013-12-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
Sponsor: Sandoz
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Plaque Type Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None plaque type psoriasis View
None equivalent efficacy View
None safety and immunogenicity View
None GP2017 View
None Humira® View